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Edited by Angel NebredaAbstract The eﬀect of double-strand DNA breaks (DSBs) on
the spindle assembly checkpoint (SAC) has important implica-
tions with respect to the relationship between SAC function
and chromosome instability of cancer cells. Here, we demon-
strate that induction of DSBs in mitosis results in prolonged hy-
per-phosphorylation of the SAC protein BubR1 and association
of BubR1 with kinetochores in mammalian cells. Combining sin-
gle cell time-lapse microscopy with immunoﬂuorescence, ﬂow
cytometry, and Western blot analysis in synchronized cells, we
provide evidence that DSBs activate BubR1, leading to promet-
aphase arrest. Accordingly, elimination of BubR1 expression by
siRNA resulted in the abrogation of mitotic delay in response to
chromosome damage. These results suggest that BubR1 links
DNA damage to kinetochore-associated SAC function.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Kinetochore1. Introduction
Growing cells experience continuous genotoxic damage. To
ensure that progeny are genetically equivalent, cells possess
checkpoint controls in response to genotoxic insults that could
compromise genetic integrity. In eukaryotic cells, G1 and G2
checkpoints mediated by the ATM and ATR kinases detect
DNA damage and ensure that the damage is repaired before
entry into mitosis [1,2]; however, rapidly growing cells such
as tumor cells, which often have mutations in the G1 and
G2 checkpoints, may encounter DNA damage after they have
committed to mitosis when the chromosomes are already con-
densed. If the cell is to maintain genetic integrity in this situa-
tion, it must either commit suicide or develop another
checkpoint control within mitosis to delay progression of mito-
sis and manage the damage. Studies in yeast [3] and ﬂies [4,5]
indicate that DNA damage induces a mitotic delay through
activation of the spindle assembly checkpoint (SAC); however,
it is not clear yet whether a similar mechanism exists in mam-
malian cells.Abbreviations: APC/C, anaphase promoting complex/cyclosome; SAC,
spindle assembly checkpoint; DSB, double-strand DNA break
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doi:10.1016/j.febslet.2008.04.028Mammalian cells exposed to double-strand DNA breaks
(DSBs) during terminal G2 or the early stages of mitosis appear
to harbor chromosome fragments that persist until anaphase
[6,7], suggesting that DNA repair are not eﬃcient under the
constraint of condensed chromosomes. It is thought that mam-
malian cells tend to correct the damage in the next G1 or expe-
rience sudden mitotic cell death [6], also known as mitotic
catastrophe [8,9]. In contrast, work from Nitta et al. [10] sug-
gests that the SAC can respond to DNA damage in mammalian
cells. They showed that DNA damage activates SAC in p53-
dysfunctional cells and leads to mitotic catastrophe. Further,
they demonstrated that elimination of SAC components
BubR1 orMad2 abrogates mitotic cell death and result in chro-
mosome mis-segregation. These ﬁndings are consistent with the
hypothesis that phenotypic aneuploidy in cancer cells arises
from impaired DNA repair in conjunction with a dysfunctional
mitotic checkpoint [11,12].
The SAC monitors whether microtubule spindles are all at-
tached to kinetochores and whether all kinetochores are under
tension from bi-polar spindles. A single unattached chromo-
some is suﬃcient to activate the SAC and delay mitosis
through inhibition of the APC/C ubiquitin ligase, which de-
grades cyclin B and securin [13–15]. BubR1, like Mad2, inhibit
APC/C by binding to Cdc20, or through inhibition of APC/C
ubiquitin ligase activity as components of the mitotic check-
point complex (MCC) [15,16]. Notably, previous study using
laser microsurgery showed that extensive DNA damage in
mammalian cells that are committed to divide delays the meta-
phase–anaphase transition through SAC component Mad2
[17]. It is not known whether BubR1 is involved.
The aim of this study was to determine which stage of mito-
sis after chromosome condensation is aﬀected by DSB. We
were particularly interested to know if BubR1 responds to
DSB in mitosis because BubR1 has been shown to respond
to DSBs in ﬂies [4], is a critical component of SAC signaling
[18–22], and is also implicated in tumorigenesis [23–25].2. Results
2.1. DNA damage in mitosis induces prometaphase arrest
We ﬁrst conﬁrmed the presence of DNA damage in mitotic
cells by immunostaining with antibody to c-H2AX, since phos-
phorylated H2AX (c-H2AX) is detected at sites of DNA
damage [26]. To avoid complications caused by activation of
interphase checkpoints, we used cells that were synchronized
at prometaphase in all experiments. Normal mouse embryonicblished by Elsevier B.V. All rights reserved.
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dazole then challenged with the radiomimetic drug doxorubicin
for 6 h and immunostainedwith antibodies to c-H2AX.CREST
serum or anti-BubR1 antibodies were used to mark the kineto-
chores. Doxorubicin-treated nocodazole arrested cells con-
tained c-H2AX-positive foci (Fig. 1). CREST or BubR1
staining at the kinetochores and the presence of condensed chro-
matin, as revealed by DAPI staining, indicate that the cells were
in prometaphase. These data conﬁrm that treatment with doxo-
rubicin induced DSBs in prometaphase in normalMEFs as well
as HeLa cells, even when the chromosomes were condensed.
We next investigated the eﬀect of DSB on the checkpoint
control for mitotic progression. HeLa cells were synchronized
with nocodazole for 13 h, washed, and treated with doxorubi-
cin or mitomycin C to induce DNA damage. At 2 h and 5 h
after nocodazole release and drug treatment, cells were ﬁxed
and stained with DAPI to score for their stage in mitosis.
When asynchronously growing cells were treated with doxoru-
bicin for 13 h, the majority of the cells were arrested in pro-
phase or G2 (Fig. 2A), while nocodazole-treated cells were
arrested at prometaphase (Fig. 2B). Asynchronous cells treated-
D
ox
+
D
ox
CRESTH2AX DA
CRESTH2AX DA
-
D
ox
+
D
ox
A
B
C
-
D
ox
+
D
ox
BubH2AX CREST
γ
γ
γ
Fig. 1. DSB in prometaphase chromosomes. (A, B) MEFs were synchronized
or untreated (Dox). Cells were ﬁxed and co-stained with c-H2AX and CR
chromosomes. (C) HeLa cells were treated and immunostained as in MEFs.with mitomycin C were arrested in prophase (50%) and pro-
metaphase (46%). The eﬀects of DNA damage on synchro-
nized cells were noticeably diﬀerent. Two hours after
nocodazole release, untreated cells progressed to anaphase
(6%) and cytokinesis (18%) and 5 h after nocodazole release,
31% of the cells were in cytokinesis. In sharp contrast, syn-
chronized cells treated with 2.4 lM doxorubicin or 10 lM
MMC were arrested in prometaphase even at 5 h after release.
DNA topoisomerase II (topo II) activity is required for meta-
phase–anaphase transition [27,28]. To distinguish between the
eﬀects of DSB formation and inhibition of decatenation, we
compared two diﬀerent topo II inhibitors, doxorubicin and
ICRF-193. Doxorubicin inhibits topo II activity by stabilizing
DNA-topo II complexes thereby blocking re-ligation and caus-
ing DSB, but does not aﬀect the catalytic decatenation activity.
ICRF-193 inhibits the catalytic activity of topo II by blocking
formation of the covalent intermediate between the DNA
strands and topo II without causing DNA damage [29].
In contrast to doxorubicin treatment, inhibition of topo II
catalytic activity by 100 lM ICRF-193 induced metaphase
arrest for 2 h after release. Cells progressed to anaphase byPI Merge
PI Merge
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H2AX
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at prometaphase then treated with 2.4 lM doxorubicin for 6 h (+Dox)
EST (A) or anti-BubR1 antibodies (B). Blue represents DAPI-stained
Images were obtained and merged as marked.
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Fig. 2. Mitotic phase distribution following DNA damage. (A) Asynchronously growing HeLa cells were treated with Noc, Dox, MMC, or 100 lM
ICRF-193 (ICRF) for 13 h. When assessing the eﬀects of DNA damage in mitosis, nocodazole arrested cells were washed, then challenged with the
drugs indicated for 2 h and 5 h, respectively. In each experimental set, 1000 DAPI-stained cells were scored. (B) Mitotic phase from (A) were analyzed
further in detail. Approximately 200 cells from (A) were counted and scored. The data represent average scoring of two independent experiments.
1702 E. Choi, H. Lee / FEBS Letters 582 (2008) 1700–17065 h (Fig. 2B). This is consistent with reports that inhibition of
DNA decatenation interferes with metaphase–anaphase transi-
tion [27,30,31] and suggests that DSB and decatenation in-
duces distinct checkpoint controls. Skouﬁas et al. [31]
previously reported that DNA damage does not activate the
SAC; the discrepancy with our data may be due to diﬀerences
in the drug concentration used or in the method of analysis.
We used half the concentration of drugs compared to Skouﬁas
and colleagues work, because we observed massive cell death
from high concentration of drug treatment.
We then analyzed mitotic timing following treatment with
doxorubicin at the single cell level. H2B-GFP-encoding plas-
mids were transfected into T98G cells before nocodazole arrest
and synchronization to facilitate observation of chromosome
movement in live cell imaging. Time-lapse microscopy showed
that anaphase was delayed for up to 13 h when prometaphase
cells encountered DSBs, whereas untreated cells entered ana-
phase within 45 min of release (Fig. 3A and Supplementary
movies 1 and 2). Similar results were obtained in normal
MEFs (Fig. 3B and Supplementary movies 3–5), indicating
that DSB induction after chromosome condensation induces
prometaphase arrest in both normal and cancer cell lines.
2.2. DNA damage-induced prometaphase arrest requires BubR1
We next examined the role of BubR1 in the induction of pro-
metaphase arrest by DNA damage. The phosphorylation status
of BubR1 is closely linked to SAC activity and is crucial formito-
tic timing. Notably, BubR1 monitors kinetochore-microtubule
attachments [20,32] and the signal generated by unattached kine-tochores induces hyper-phosphorylation of BubR1 [19], which
appears as a characteristic slower migrating band [33].
SynchronizedHeLa cells were released into the cell division cy-
cle with or without doxorubicin treatment and assessed for
BubR1 status by western blot, and analyses for cell cycle stage
were performed at diﬀerent time points after release (Fig. 4).
Cycloheximide treatmentswere included toblockdenovo synthe-
sis of the protein. Cells that were not treated with doxorubicin
progressed into anaphase 2 h after nocodazole release (Fig 4B),
and the level of phospho-BubR1 was markedly reduced at this
point (Fig. 4A). In comparison, treatment with doxorubicin re-
sulted in attenuated phosphorylation of BubR1 that persisted
for more than 6 h, concomitant with a delay in cell division.
Next, we assessed the intracellular localization of BubR1 fol-
lowing induction of DSBs. Direct inhibition of APC/C by the
MCC, which requires BubR1, can occur away from the kineto-
chores [34], whereas the role of BubR1 in monitoring kineto-
chore-microtubule attachments [20,32] and checkpoint
signaling [18,19,21] requires its localization to kinetochores. In
the presence of DSB induced by doxorubicin or MMC, BubR1
was predominantly associatedwith prometaphase kinetochores.
Interestingly, BubR1-positive foci were larger inDNAdamaged
cells than in normal cycling cells (Fig. 5). The nature of this large
BubR1-containing complex warrants future investigation.
Finally, we assessed the role of BubR1 in mitotic progression
when cells encountered DSB. HeLa cells transfected with siR-
NA for BubR1 or control siRNAwere synchronized, then chal-
lenged with doxorubicin as in Fig. 4. Doxorubicin treatment in
control cells showed attenuated phospho-BubR1 and delay in
00:00 00:30 01:51 02:03
00:03 00:27 00:45 00:51 01:15
Co
nt
ro
l
+
D
ox
06:24
A
B
00:00 02:00 03:00 03:20 03:40
00:00 00:40 01:00 01:10 02:10
00:00 03:40 04:00 04:20 08:31
Co
nt
ro
l
+
D
ox
Fig. 3. DNA damage after chromosome condensation delays chromosome segregation. (A) T98G cells were transfected with H2B-GFP expression
construct and synchronized with nocodazole. Following release from nocodazole arrest, cells were either untreated or treated with doxorubicin and
subjected to time-lapse microscopy. Images were captured at indicated time points. (B) Time-lapse microscopy of synchronized normal MEFs
transfected with H2B-GFP. Captured images are representative of at least ﬁve diﬀerent time-lapse microscopic analyses.
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parison, doxorubicin treatment in cells repressed for BubR1
expression (Fig. 5B, siBubR1) did not show apparent check-
point response but entered anaphase in 2 h as in untreated cells
(Fig. 5C, siBubR1). Collectively, these results suggest that DSB
after chromosome condensation induces kinetochore-associ-
ated BubR1 phosphorylation and SAC activation.3. Discussion
Our results show that formation ofDSBs inmitosis induces pro-
longed hyper-phosphorylation and kinetochore association of
BubR1 leading to prometaphase arrest. In contrast, inhibition of
topo II catalytic activity resulted in metaphase arrest. This diﬀer-
ence implies thatDSB formation and inhibition ofDNAdecatena-
tion generate distinct signals. We speculate that inhibition of
decatenation does not induceDSBs but aﬀects the tension between
sister chromatids, whereas DSBs might alter chromosome topol-
ogy and hence the organization of kinetochores. Our ﬁndings
therefore suggest that the decatenation checkpoint [31,35,36] is dis-
tinct from theDSB-induced SACand indicate thatmultiple check-
point mechanisms may control mitotic progression.
Then what is the signiﬁcance of BubR1 phosphorylation and
kinetochore association in the presence of DSBs? BubR1 plays
an essential role in kinetochore localization and assembly of
other SAC components [19], and also regulates chromosome-
spindle attachments [20]. Therefore, it is possible that BubR1responds to altered chromosome topology caused by DSBs be-
cause this aﬀects kinetocore-microtubule attachment and asso-
ciated events. Alternatively, DSB-induced BubR1 hyper-
phosphorylation may be required to induce mitotic cell death
in the end [10]. Studies in yeast [12] and BRCA2-deﬁcient cells
[11] suggested that DNA repair may be coordinated with mito-
tic checkpoints. Therefore, one possibility is that SAC activa-
tion in response to DSB cross-talks with an as-yet-unidentiﬁed
DNA repair. In this vein, it is interesting to note that a key
component in DNA damage checkpoint, Chk1, is required
for sustained anaphase delay upon taxol treatment [37].
Our study indicates that BubR1 plays an important role in
the DNA damage response. Since accumulated DNA lesions
cause cancer, our data suggest that inactivation of BubR1
may be involved in the initiation stage of tumorigenesis:
impaired BubR1 phosphorylation or insuﬃcient level of kine-
tochore-associated BubR1 due to mutation of BubR1-regulat-
ing factors may initiate chromosome instability without
apparent BubR1 mutation.4. Materials and methods
4.1. Antibodies and Western blot analysis
Antibodies were purchased as indicated: anti-b-Actin (AC-15) and
anti-Flag (M2), Sigma–Aldrich; anti-BubR1, BD Biosciences; CREST,
Cortex Biochem; anti-cH2AX, TREVIGEN. Anti-Lamin A/C mono-
clonal antibody was a gift from Prof. F. McKeon (Harvard Medical
School).
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Fig. 4. Chromosome damage results in sustained BubR1 phosphorylation concomitant with delayed progression into anaphase. (A) Western blot
analysis of BubR1. Cells were synchronized in prometaphase with nocodazole and subjected to mitotic-shake oﬀ, then washed and released into the
cell cycle (None). Cells remained attached after mitotic-shake oﬀ, thus in interphase, were included for control (Attch). Nocodaozle released cells
were treated with Dox with or without 100 lg/mL cycloheximide (CHX) for the time points indicated. The blots were reprobed with anti-Lamin A/C
antibody to normalize protein levels. (B) Eﬀects of DNA damage on cell cycle progression at diﬀerent time points following Dox treatment as in (A).
2N and 4N DNA contents are marked.
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Synthetic siRNA for BubR1 were designed against 3 0-UTR
(GUCUCACAGAUUGCUGCCUTT) and siRNA for GFP (GUU-
CAGCGUGUCCGGCGAGTT) was employed for control. Duplex
siRNAs were obtained from Samchully Pharmacy Com. (Daejeon,
Korea). 240 nM of duplex siRNAs were transfected into HeLa cells
using oligofectamine (Invitrogen).
4.3. Time-lapse video microscopy
Cells were grown in 35-mm Delta-T dishes (Bioptechs Inc., Butler,
PA) and transfected with pBOS-GFP-H2B. For synchronization in
prometaphase, T98G cells were treated for 13 h with 200 ng/mL
nocodazole, or 400 ng/mL nocodazole for MEFs. Synchronized cellswere washed three times with PBS and incubated in fresh media with
or without doxorubicin. Time-lapse ﬂuorescence and DIC micros-
copy were performed with a CoolSnap HQ-cooled CCD camera on
a DeltaVision Spectris Restoration microscope built around an
Olympus IX70 stand, with a 20·/0.75 NA lens (AppliedPrecision).
Images were acquired every 3 min for T98G cells and every 10 min
for MEFs.
4.4. Immunoﬂuorescence microscopy
For indirect immunoﬂuorescence microscopy, cells were ﬁxed with
4% paraformaldehyde, permeabilized twice in PBS containing 0.5%
Triton X-100 for 15 min at room temperature, then incubated in
blocking buﬀer (10% goat serum in 0.1% PBST) for 1 h at room
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Fig. 5. BubR1 association with prometaphase kinetochores after chromosome damage. HeLa cells were arrested in prometaphase, washed, and
treated with Dox (+Dox) or MMC (+MMC) for 2 h prior to staining with anti-BubR1 antibodies and DAPI. (B, C) HeLa cells were transfected with
siRNA for BubR1 (siBubR1) or control (siControl), synchronized in prometaphase as in Fig. 4, released, challenged with or without doxorubicin,
then analyzed for their cell cycle stages at the indicated time points (C). Concomitantly, BubR1 level was assessed by Western blot. Same blot was
reprobed for anti-Lamin A/C (B). Cells remained attached after mitotic-shake oﬀ, were included for control (Attch).
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blocking buﬀer for 1 h, followed by incubation with secondary anti-
bodies in blocking buﬀer. After a ﬁnal rinse, the cells were mountedon microscope slides in VECTASHIELD containing DAPI. Images
obtained from DeltaVision were acquired as a series of 0.4 lm-thick
image sections and merged.
1706 E. Choi, H. Lee / FEBS Letters 582 (2008) 1700–17064.5. Flow cytometric analysis of cell cycle
Cells were ﬁxed with cold 70% ethanol, and stained with propidium
iodide (PI) for FACS analysis (FACSCalibur; Becton Dickinson,
Franklin Lakes, NJ). Data were processed using CellQuest software.
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